The Chinese Embassy in Dhaka has issued an urgent warning regarding applications for medical visas, urging applicants to exercise caution and follow proper procedures to avoid rejection. In a notice ...
All of us in the BRSU are incredibly proud of Tamsin,” said Bennington Rutland Supervisory Union (BRSU) Superintendent Randi ...
The ROC held that issuing offer letters and using funds before statutory filings amounts to a substantive violation of Section 42, attracting penalties under Section ...
Self-represented prisoners face significant disadvantages when seeking justice through conviction integrity units, with some ...
The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
The Kenya Times on MSN
VFS Global addresses visa payment refunds for Kenyan applicants after failed booking process
VFS Global has issued guidance for Kenyan and other foreign nationals experiencing issues with the visa payment gateway. In a ...
Investing.com -- Sanofi SA (EPA:SASY) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application of tolebrutinib, which was ...
The Prescription Drug User Fee Act target guidelines for NDA resubmissions include acknowledgment of acceptance for review ...
VANCOUVER, BC, Dec. 29, 2025 /PRNewswire/ - BTQ Technologies Corp. ( "BTQ" or the "Company") (Nasdaq: BTQ) (CBOE CA: BTQ) ...
Wondering how to find a new job, but getting frustrated because you’ve applied over and over with no response? Your resume ...
That scuppered Sanofi's plans for filing tolebrutinib in PPMS, and the FDA has now slammed the brakes on its efforts to get ...
Stocktwits on MSN
Vanda’s FDA moment: A high-stakes bet that could redefine the stock
November, erasing the stock’s losses for the year amid a series of news flows. ・Tradipitant previously failed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results